Immune and neural cells in the CNS microenvironment

The CNS microenvironment is a complex biological system comprising neural cells—such as neurons, astrocytes, microglia, and oligodendrocytes—and their dynamic interactions with the immune system. This environment is essential for maintaining physiological homeostasis, supporting neurotransmission, and orchestrating the brain's response to pathological insults (Source: Nature Reviews Neuroscience, 2017). In conditions like Multiple Sclerosis, Alzheimer's disease, and malignant gliomas, the balance within this niche is disrupted, often resulting in chronic neuroinflammation or immune evasion (Source: NIH, 2021). Pharmacological intervention typically involves targeting specific receptors or signaling molecules on these cells to modulate the overall environment. For instance, therapies may aim to prevent the migration of peripheral leukocytes across the blood-brain barrier or to polarize microglia toward a neuroprotective phenotype (Source: PubMed, 2022). Consequently, while not a single molecular target, the CNS microenvironment represents a critical therapeutic landscape for treating diverse neurological and psychiatric disorders.

Other names

CNS microenvironmentNeuroimmune nicheBrain microenvironmentNeurovascular unitCNS immune-neural interface

Drugs targeting this environment act through various mechanisms including the antagonism of alpha-4 integrins to prevent leukocyte trafficking, depletion of CD20-positive B-cells, modulation of sphingosine-1-phosphate receptors to sequester lymphocytes, and inhibition of acetylcholinesterase to enhance cholinergic signaling.